FDA Approved: DOFETILIDE 0.125MG — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of dofetilide (0.125 mg) from Granules Pharmaceuticals Inc., expanding access to this antiarrhythmic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Dofetilide 0.125 mg (dofetilide)

Snippet

ORIG AP for DOFETILIDE 0.125MG (DOFETILIDE 0.125MG)